Glimepiride Tablets Manufacturer Supplier in PCD Pharma Franchise
BRAND NAME FOR Glimepiride Tablets IN PCD PHARMA FRANCHISE – GLIMSU – 1
COMPOSITION: Glimepiride Tablets IP 1 MG
For rates and Schemes – Contact 8284010553
Introduction of Glimepiride Tablets
GLIMSU – 1, manufactured by Matins Pharma, is a brand of Glimepiride Tablets IP 1 MG. Glimepiride belongs to the sulfonylurea class of antidiabetic medications and is used for the management of type 2 diabetes mellitus. It works by stimulating the release of insulin from pancreatic beta cells, thereby lowering blood glucose levels.
Uses of Glimepiride Tablets
- Diabetes Management: GLIMSU – 1 is indicated for the treatment of type 2 diabetes mellitus, particularly in patients whose blood sugar levels are not adequately controlled by diet and exercise alone. It helps lower blood glucose levels by increasing insulin secretion from the pancreas and improving insulin sensitivity in peripheral tissues.
- Glycemic Control: By lowering blood sugar levels, GLIMSU – 1 helps reduce the risk of diabetes-related complications such as cardiovascular disease, neuropathy, nephropathy, and retinopathy. It is an essential component of comprehensive diabetes management aimed at achieving and maintaining optimal glycemic control.
Side Effects of Glimepiride Tablets
While GLIMSU – 1 is generally well-tolerated, it may cause some side effects in some individuals. Common side effects include:
– Hypoglycemia (low blood sugar): Glimepiride can cause hypoglycemia, especially if taken with insufficient food intake or in combination with other antidiabetic medications. Symptoms of hypoglycemia include sweating, trembling, confusion, and palpitations.
– Weight gain: Some patients may experience weight gain while taking GLIMSU – 1, which is often attributed to improved glycemic control and increased appetite.
– Gastrointestinal disturbances: Mild gastrointestinal side effects such as nausea, vomiting, and diarrhea may occur in some individuals.
Rare but serious side effects of Glimepiride include allergic reactions, severe hypoglycemia, and hepatotoxicity. Patients should seek medical attention if they experience any unusual or severe symptoms.
Safety Advice of Glimepiride Tablets
– Regular Monitoring: Patients taking GLIMSU – 1 should undergo regular monitoring of blood glucose levels to assess the effectiveness of treatment and detect hypoglycemia or hyperglycemia.
– Hypoglycemia Prevention: To minimize the risk of hypoglycemia, patients should follow a consistent meal plan, avoid skipping meals, and monitor blood sugar levels regularly. They should also be educated about the signs and symptoms of hypoglycemia and how to treat it promptly.
– Medication Adjustments: Dosage adjustments may be necessary based on individual patient response and changes in lifestyle, diet, or concomitant medications.
Dosage of Glimepiride Tablets
The recommended starting dose of GLIMSU – 1 is 1 mg once daily, taken with breakfast or the first main meal of the day. The dosage may be adjusted based on the patient’s glycemic response, with a maximum recommended dose of 8 mg daily.
The onset of action of GLIMSU – 1 is relatively rapid, with peak plasma concentrations reached within 2 to 3 hours after oral administration. However, the full therapeutic effect in terms of glycemic control may take several days to weeks of continuous treatment. Patients should continue taking GLIMSU – 1 as prescribed by their healthcare provider and follow up regularly for monitoring and dose adjustments as needed.
MATINS PHARMA IS A LEADING MANUFACTURER / SUPPLIER OF Glimepiride Tablets
Matins Pharma, a leading manufacturer and supplier in the pharmaceutical industry, offers high-quality Glimepiride Tablets IP 1 MG under the brand name GLIMSU – 1.
Matins Pharma is one of the fastest growing Manufacturers suppliers pan India.
WE AT MATINS PHARMA AIM FOR :
- 100% quality assurance with high efficacy and excellent results
- Improved delivery experience and shorter delivery times
- Best in class service levels through regular communication with our Supplier partners and sharing the same in a transparent manner
- Customer satisfaction and understanding the latent needs of the our business partners
- Enriching our product mix by each passing day so as to provide you everything under one roof
Why Matins Pharma is among the best PCD Pharma Franchise Company in India:
- 100 % Quality Assurance
- Direct Dealing with Company Owners
- Very High Efficacy, WHO/GMP/GLP Certified Products
- Wide Product Range
- Best in Class Packings with UV Drip Off Finish
- High Margin Products with genuine rates
- Same Day Dispatch with trusted delivery partners
- Fair and Transparent Dealing – 100 % Commitment to agreement
Address: D-1A, Ahluwalia Complex Vill. Fatehpur, Sector 20, Panchkula, 134117, Haryana
Contact Number: 82840 10553, 99155 69932, 94175 06219India
We at Matins Pharma provide wide range of quality products. We offer the following ranges in PCD Pharma Franchise:
About Us
Matins Pharma is one of the fastest growing PCD Pharma company in the Indian Pharma Industry. We made foray into the pharma business in 1996 and entered the PCD domain in 2014. We have been supplying finished pharma supplies under PCD franchise model for past 5 years and we have had excellent results.
Our Office Hours
Mo-Fr: 8:00-19:00
Sa: 8:00-14:00
So: closed
Contact Info
Mr. Rakesh Kansal
Phone:-(91)-8284010553
Phone:-(91)-9417506219
SCO: D-1A, Ahluwalia Complex
Vill. Fatehpur, Sector 20
Panchkula – 134117
Haryana